Search Results
Sep 07, 2026, 02:02 ET Multiconsult and Rejlers to create a leading pan-Nordic multidisciplinary consultancy group through a merger of equals
and Stiftelsen Multiconsult. For further information, reference is made to the statement from the Swedish Securities Council dated 3 September 2026 (AMN 2026-:44).INVESTOR PRESENTATIONA virtual investor presentation (the "Investor Presentation") will be arranged today at 10:00 CEST.
More news about: Multiconsult
Sep 07, 2026, 01:58 ET Multiconsult and Rejlers to create a leading pan-Nordic multidisciplinary consultancy group through a merger of equals
and Stiftelsen Multiconsult. For further information, reference is made to the statement from the Swedish Securities Council dated 3 September 2026 (AMN 2026-:44).INVESTOR PRESENTATIONA virtual investor presentation (the "Investor Presentation") will be arranged today at 10:00 CEST.
More news about: Multiconsult
Aug 28, 2026, 10:00 ET If you had interpretation sessions from AMN Healthcare or AMN Healthcare Language Services, your sessions may have been monitored or recorded without your consent, and your rights may be affected by a settlement
v. AMN Healthcare, Inc. et al., Case No. 37-2023-00052448-CU-NP-CTL (Superior Court of the State of California, County of San Diego). A proposed settlement has been reached with AMN Healthcare, Inc. and AMN Healthcare Language Services, Inc. ("AMN") in a class action alleging that AMN violated
More news about: Kroll Settlement Administration LLC
Aug 28, 2026, 10:00 ET Si tuvo sesiones de interpretación por parte de AMN Healthcare o AMN Healthcare Language Services, es posible que sus sesiones hayan sido monitoreadas o grabadas sin su consentimiento, y sus derechos pueden verse afectados por un acuerdo.
Carrero, et al. contra AMN Healthcare, Inc. et al., caso n.º 37-2023-00052448-CU-NP-CTL (Tribunal Superior del Estado de California, Condado de San Diego). Se llegó a un acuerdo propuesto con AMN Healthcare, Inc., y AMN Healthcare Language Services, Inc., ("AMN") en una demanda colectiva
More news about: Kroll Settlement Administration LLC
Aug 25, 2026, 14:13 ET Royce Micro-Cap Trust (NYSE: RMT) as of Jul 31, 2026
1.2AMN Healthcare Services1.2
More news about: Royce Micro-Cap Trust, Inc.
Aug 17, 2026, 09:00 ET AMN Healthcare Joins AONL Foundation's Corporate Advisory Council to Advance Nursing Leadership
Through its membership, AMN will engage with nurse and industry leaders to support research, innovation and educational initiatives that help advance nursing leadership nationwide. AMN will be represented on the council by Dr. Angelo Venditti, Chief Nursing
More news about: AMN Healthcare Services, Inc.
Aug 12, 2026, 08:28 ET AMN Healthcare Report Projects Persistent Workforce Strain Across Nursing, Allied Health, Physicians and Advanced Practitioners Through 2030
update or revise any forward-looking statements whether as a result of new information, future events, or otherwise.About AMN HealthcareAMN Healthcare is the leader and innovator in total talent solutions for health care, bringing together the people, processes and technology
More news about: AMN Healthcare Services, Inc.
Aug 06, 2026, 16:15 ET AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2026 RESULTS
2026 AMN Healthcare Services, Inc. (NYSE: AMN) will host a conference call to discuss its second quarter 2026 financial results and third quarter 2026 outlook on Thursday, August 6, 2026 at 5:00 p.m. Eastern Time. A live webcast of the call can be accessed through AMN Healthcare's website
More news about: AMN Healthcare Services, Inc.
Jul 07, 2026, 16:15 ET AMN Healthcare to Hold Second Quarter 2026 Earnings Conference Call on Thursday, August 6, 2026
DALLAS, July 7, 2026 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its second quarter 2026 financial results and third quarter 2026 outlook on Thursday, August 6, 2026,
More news about: AMN Healthcare Services, Inc.
Jun 24, 2026, 10:42 ET AMN Healthcare and Brightfield Launch First-of-its-Kind Healthcare Partnership Advancing Workforce Intelligence and Market Transparency
spendMove from reactive staffing decisions to more proactive workforce planning backed by even more market dataAbout AMN HealthcareAMN Healthcare is the leader and innovator in total talent solutions for healthcare, bringing together the people, processes and technology
More news about: AMN Healthcare Services, Inc.
Jun 24, 2026, 07:05 ET Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults
agonist for the potential treatment of X-linked adrenoleukodystrophy (X-ALD). In a Phase 1b clinical trial in patients with the adrenomyeloneuropathy (AMN) form of X-ALD, VK0214 was shown to be safe and well-tolerated, while driving significant reductions in plasma levels of very long-chain fatty acids
More news about: Viking Therapeutics, Inc.
Jun 23, 2026, 16:15 ET SIKORA Unveils New Software Program for the Wire and Cable Industry
Pulverizing Systems, Recycling Systems and Measurement & Control Systems divisions consolidate the many years of experience and in-depth know-how of the AMN, AUTOMATIK, ETTLINGER, GALA, MAAG, REDUCTION, SCHEER, SIKORA, WITTE and XANTEC product brands. The MAAG Group currently employs over 1,900 people at
More news about: Dover
Jun 23, 2026, 11:05 ET MY DR NOW Is Coming to Texas with a Same-Day Primary Care Model
additional primary care practitioners needed to remove those designations. Nationally, access to family medicine appointments remains strained: a 2025 AMN Healthcare survey summarized by the American Academy of Family Physicians found that new patients waited an average of 23.5 days for a family medicine
More news about: MY DR NOW
Jun 18, 2026, 15:30 ET AMN Healthcare Acquires Leadership Assessment Solution to Advance Executive Search and Leadership Advisory Capabilities
executive search practice, AMN will deliver additional value to healthcare clients at the executive level and support a broader set of workforce and leadership priorities over time. Financial terms of the transaction were not disclosed.About AMN HealthcareAMN Healthcare is the leader
More news about: AMN Healthcare Services, Inc.
Jun 15, 2026, 09:00 ET AMN Healthcare Names New Chief Commercial Officer and Chief People Officer to Advance Growth and Culture
an organization that is more connected, more agile, and well equipped to execute with speed and quality," added Grace.About AMN Healthcare AMN Healthcare is the leader and innovator in total talent solutions for healthcare, bringing together the people, processes and technology
More news about: AMN Healthcare Services, Inc.
Jun 12, 2026, 11:57 ET MY DR NOW Addresses Provider Shortage, Opening Fifth Gilbert Clinic
and surrounding East Valley communities, where family doctors have struggled to keep pace with rapid family-driven growth.The need is acute. AMN Healthcare's 2025 Survey of Physician Appointment Wait Times found the average wait for a new-patient family medicine appointment is now 23.5 days nationally,
More news about: MY DR NOW
Jun 11, 2026, 07:05 ET Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D., as Chief Medical Officer
beta agonist for the potential treatment of X-linked adrenoleukodystrophy (X-ALD). In a Phase 1b clinical trial in patients with the adrenomyeloneuropathy (AMN) form of X-ALD, VK0214 was shown to be safe and well-tolerated, while driving significant reductions in plasma levels of very long-chain fatty acids
More news about: Viking Therapeutics, Inc.
May 27, 2026, 05:41 ET Bulletin from the Extraordinary General Meeting of AB Electrolux
AMN 2026:03). The resolution of the General Meeting as described above was adopted as one resolution.Minutes from the Extraordinary General Meeting
More news about: Electrolux Group
May 27, 2026, 05:36 ET Bulletin from the Extraordinary General Meeting of AB Electrolux
AMN 2026:03). The resolution of the General Meeting as described above was adopted as one resolution.Minutes from the Extraordinary General Meeting
More news about: Electrolux Group
May 21, 2026, 07:05 ET Viking Therapeutics to Participate at Upcoming Investor Conferences
beta agonist for the potential treatment of X-linked adrenoleukodystrophy (X-ALD). In a Phase 1b clinical trial in patients with the adrenomyeloneuropathy (AMN) form of X-ALD, VK0214 was shown to be safe and well-tolerated, while driving significant reductions in plasma levels of very long-chain fatty acids
More news about: Viking Therapeutics, Inc.
May 12, 2026, 07:05 ET Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026
beta agonist for the potential treatment of X-linked adrenoleukodystrophy (X-ALD). In a Phase 1b clinical trial in patients with the adrenomyeloneuropathy (AMN) form of X-ALD, VK0214 was shown to be safe and well-tolerated, while driving significant reductions in plasma levels of very long-chain fatty acids
More news about: Viking Therapeutics, Inc.
May 07, 2026, 11:03 ET Generations Retirement Group Expands Outreach to Massachusetts Nurses
AMN Healthcare, approximately 33% of the nursing workforce is eligible or nearing eligibility for retirement, while 40% of registered nurses indicate
More news about: Generations Retirement Group
May 05, 2026, 07:05 ET Viking Therapeutics Announces Two Poster Presentations at European Congress on Obesity (ECO) 2026
agonist for the potential treatment of X-linked adrenoleukodystrophy (X-ALD). In a Phase 1b clinical trial in patients with the adrenomyeloneuropathy (AMN) form of X-ALD, VK0214 was shown to be safe and well-tolerated, while driving significant reductions in plasma levels of very long-chain fatty acids
More news about: Viking Therapeutics, Inc.
Apr 29, 2026, 16:05 ET Viking Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
agonist for the potential treatment of X-linked adrenoleukodystrophy (X-ALD). In a Phase 1b clinical trial in patients with the adrenomyeloneuropathy (AMN) form of X-ALD, VK0214 was shown to be safe and well-tolerated, while driving significant reductions in plasma levels of very long-chain fatty acids
More news about: Viking Therapeutics, Inc.
Apr 23, 2026, 12:09 ET Electrolux Group accelerates profitable growth strategy through a partnership with Midea, global organization and footprint optimization, and a fully underwritten rights issue of approx. SEK 9 billion
disregarded. Investor AB's guarantee undertaking is conditional upon said majority being received at the EGM.The Swedish Securities Council's ruling (AMN 2026:03) will be made available on the Swedish Securities Council's website (
More news about: Electrolux Group